APA (7th ed.) Citation

Maes, K., Hose, D., & Seckinger, A. (2015). In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma. OncoTarget, 6(5), . https://doi.org/10.18632/oncotarget.3207

Chicago Style (17th ed.) Citation

Maes, Ken, Dirk Hose, and Anja Seckinger. "In Vivo Treatment with Epigenetic Modulating Agents Induces Transcriptional Alterations Associated with Prognosis and Immunomodulation in Multiple Myeloma." OncoTarget 6, no. 5 (2015). https://doi.org/10.18632/oncotarget.3207.

MLA (9th ed.) Citation

Maes, Ken, et al. "In Vivo Treatment with Epigenetic Modulating Agents Induces Transcriptional Alterations Associated with Prognosis and Immunomodulation in Multiple Myeloma." OncoTarget, vol. 6, no. 5, 2015, https://doi.org/10.18632/oncotarget.3207.